Effects of brown seaweeds on postprandial glucose, insulin and appetite in humans - A randomized, 3-way, blinded, cross-over meal study

Clin Nutr. 2021 Mar;40(3):830-838. doi: 10.1016/j.clnu.2020.08.027. Epub 2020 Aug 31.

Abstract

Background & aims: Seaweed including brown seaweeds with rich bioactive components may be efficacious for a glycaemic management strategy and appetite control. We investigated the effects of two brown edible seaweeds, Laminaria digitata (LD) and Undaria pinnatifida (UP), on postprandial glucose metabolism and appetite following a starch load in a human meal study.

Methods: Twenty healthy subjects were enrolled in a randomized, 3-way, blinded cross-over trial. The study was registered under ClinicalTrials.gov Identifier no. NCT00123456. At each test day, the subjects received one of three meals comprising 30 g of starch with 5 g of LD or UP or an energy-adjusted control meal containing pea protein. Fasting and postprandial blood glucose, insulin, C-peptide and glucagon-like peptide-1 (GLP-1) concentrations were measured. Subjective appetite sensations were scored using visual analogue scales (VAS).

Results: Linear mixed model (LMM) analysis showed a lower blood glucose, insulin and C-peptide response following the intake of LD and UP, after correction for body weight. Participants weighing ≤ 63 kg had a reduced glucose response compared to control meal between 40 and 90 min both following LD and UP meals. Furthermore, LMM analysis for C-peptide showed a significantly lower response after intake of LD. Compared to the control meal, GLP-1 response was higher after the LD meal, both before and after the body weight adjustment. The VAS scores showed a decreased appetite sensation after intake of the seaweeds. Ad-libitum food intake was not different three hours after the seaweed meals compared to control.

Conclusions: Concomitant ingestion of brown seaweeds may help improving postprandial glycaemic and appetite control in healthy and normal weight adults, depending on the dose per body weight.

Clinical trial registry number: Clinicaltrials.gov (ID# NCT02608372).

Keywords: Alpha-glucosidase; Bioactive foods; Glycaemic response; Resistant dietary fibers; Satiety; Starch-degrading enzymes.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Appetite*
  • Blood Glucose / analysis*
  • C-Peptide / blood
  • Cross-Over Studies
  • Diet
  • Dietary Carbohydrates / administration & dosage
  • Female
  • Glucagon-Like Peptide 1 / blood
  • Humans
  • Insulin / blood*
  • Laminaria
  • Male
  • Meals*
  • Middle Aged
  • Phaeophyceae*
  • Postprandial Period
  • Seaweed*
  • Starch
  • Undaria
  • Young Adult

Substances

  • Blood Glucose
  • C-Peptide
  • Dietary Carbohydrates
  • Insulin
  • Glucagon-Like Peptide 1
  • Starch

Associated data

  • ClinicalTrials.gov/NCT02608372
  • ClinicalTrials.gov/NCT00123456